Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A study in patients with skin cancer Ended

2024-516914-39-00 Metastatic or unresectable melanoma 5 2022-04-27
Combination of Abemaciclib and endocrine therapy in hormone receptor positive HER2 negative locally advanced or metastatic breast cancer wit… Ended

2024-511209-49-00 Patients with hormone receptor positive HER2 negative l 6 2022-04-26
This study is to understand how well an investigational drug (called Napabucasin) works when given in combination with a chemotherapy treatm… Ended

2024-518204-50-00 Histologically confirmed adenocarcinoma of the colon or 5 2022-04-25
DISCUS: A Randomised Phase II Study Comparing 3 vs 6 Cycles of Platinum-based Chemotherapy Prior to Maintenance Avelumab in Advanced Urothel… Ended

2024-518244-20-01 Urothelial Carcinoma 4 2022-04-25
A Phase 2 study of INBRX-109 in adults with a type of unresectable or metastasized cancer of the bones and joints (Conventional Chondrosarco… Ended

2024-517528-20-00 Unresectable or metastatic conventional chondrosarcoma 4 2022-04-19
Randomized phase III trial in MMR deficient endometrial cancer patients comparing chemotherapy alone versus Dostarlimab in first line advanc… Ended

2023-510097-14-00 Patients with MMR deficient relapse or advanced / metas 5 2022-04-15
A Phase 2 Study of Sacituzumab Govitecan Combinations in First-line Treatment of Patients with Advanced or Metastatic Non−Small-Cell Lung Ca… Ended

2024-513225-23-00 Non-small cell lung cancer 4 2022-04-07
Phase 1/2 Study of Erdafitinib Intravesical Delivery System (TAR-210) in Participants with Non-Muscle-Invasive or Muscle-Invasive Bladder Ca… Ended

2023-506265-65-00 Localized Bladder Cancer 1 2022-04-07
Clinical Trial of MK-7684A with chemotherapy for extensive stage small cell lung cancer (ES-SCLC) Ended

2023-503517-30-00 Extensive-stage small-cell lung cancer 5 2022-04-01
Master Protocol of Sotorasib (AMG 510) in Subjects with Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreaK 101) Ended

2023-506794-35-00 Advanced Solid Tumors Kirsten Rat Sarcoma (KRAS) pG12C 3 2022-04-01
Phase 3 study of pembrolizumab vs chemotherapy in dMMR advanced or recurrent endometrial carcinoma Ended

2023-506361-56-00 Endometrial cancer 5 2022-04-01
Belantamab Mafodotin in combination with Daratumumab, Lenalidomide and Dexamethasone for the treatment of patients with newly diagnosed mul… Ended

2024-515634-32-00 newly diagnosed multiple myeloma 9 2022-03-31
A study to assess the Safety, Tolerability, Pharmacokinetics and Anti tumor Efficacy of DZD9008 in Patients with Advanced Non-Small Cell Lun… Ended

2024-512127-36-00 Non-Small Cell Lung Cancer 9 2022-03-31
A Phase 3 Single-Arm Study of UGN-102 for Treatment of LG IR NMIBC Ended

2023-506680-34-00 Non-Muscle Invasive Bladder Cancer 5 2022-03-24
Pembrolizumab and olaparib in recurrent/metastatic, platinum resistant nasopharyngeal cancer. POINT study Ended

2024-511901-52-00 Adult patients affected by recurrent/metastatic, platin 4 2022-03-24
Tuvusertib (M1774) in Participants with Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301) Ended

2024-515848-23-00 Metastatic or Locally Advanced Unresectable Solid Tumor 1 2022-03-18
Extension Study for Subjects Who Participated in Prior Clinical Studies of ASTX727 Ended

2024-516293-29-01 Acute myeloid lymphoma (AML), myelodysplastic syndrome 4 2022-03-17
A Study to Evaluate the Safety and Pharmacokinetics of a Modified Tafasitamab IV Dosing Regimen Combined with Lenalidomide in Patients with … Ended

2023-507993-42-00 Relapsed or Refractory Diffuse Large B-Cell Lymphoma ( 9 2022-03-17
TORNADO : RANDOMIZED PHASE II STUDY OF NEOADJUVANT CHEMOTHERAPY PLUS RETIFANLIMAB (INCMGA00012) IN PATIENTS WITH SELECTED RETROPERITONEAL SA… Ended

2023-509498-21-00 Adult patients with treatment-naïve surgically non-meta 4 2022-03-16
Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer Ended

2023-506771-10-00 Breast Neoplasm, Neoplasm Metastasis 5 2022-03-11
Master Protocol for Avelumab Continuation Study. Ended

2023-509466-38-00 Cancer 5 2022-03-08
Isa-RVD Study: Phase II, Multi-centre, Single-Arm, Open-Label Study to evaluate the efficacy and safety of the combination regimen Isatuxima… Ended

2024-512749-18-00 Newly diagnosed Multiple Myeloma 4 2022-03-03
A study of Sacituzumab Govitecan Versus Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC). Ended

2024-512148-50-00 Non-small cell lung cancer 5 2022-03-03
Clinical trial conducted to evaluate the effectiveness of a combination of drugs called venetoclax and rituximab adapted to the state of min… Ended

2024-518494-34-00 Chronic lymphocytic leukemia 4 2022-02-24